295 related articles for article (PubMed ID: 35772577)
21. Effects of Breast-Conserving Surgery and Mastectomy on the Survival of Patients with Early-Stage (T1-2N0-1M0) HER2-Positive Breast Cancer: A Propensity Score-Matched Analysis.
Zhan Q; Zhao X; Zheng G; Liu J; Wu S; Huang J; Yu L; Fu F
Oncol Res Treat; 2023; 46(12):511-519. PubMed ID: 37931609
[TBL] [Abstract][Full Text] [Related]
22. A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study).
Meattini I; Pasinetti N; Meduri B; De Rose F; De Santis MC; Franco P; Lancellotta V; Rossi F; Saieva C; Desideri I; Delli Paoli C; D'Angelo E; Triggiani L; Bastiani P; Alongi F; Lozza L; Aristei C; Ricardi U; Scorsetti M; Livi L;
Radiother Oncol; 2019 Feb; 131():208-214. PubMed ID: 30075864
[TBL] [Abstract][Full Text] [Related]
23. Breast carcinoma with 21-gene recurrence score lower than 18: rate of locoregional recurrence in a large series with clinical follow-up.
Turashvili G; Brogi E; Morrow M; Dickler M; Norton L; Hudis C; Wen HY
BMC Cancer; 2018 Jan; 18(1):42. PubMed ID: 29304773
[TBL] [Abstract][Full Text] [Related]
24. Is neoadjuvant chemotherapy necessary for T2N0-1M0 hormone receptor-positive/HER2-negative breast cancer patients undergoing breast-conserving surgery?
Liu D; Chang L; Hao Q; Ren X; Liu P; Liu X; Wei Y; Wang M; Wu H; Kang H; Lin S
J Cancer Res Clin Oncol; 2024 May; 150(5):285. PubMed ID: 38814494
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant radiation therapy alone is associated with improved overall survival compared to hormonal therapy alone in older women with estrogen receptor positive early stage breast cancer.
Jhawar SR; Alpert N; Taioli E; Sayan M; Bazan J; Park KU; Stover D; Cherian M; White J; Haffty B; Ohri N
Cancer Med; 2020 Nov; 9(22):8345-8354. PubMed ID: 32942344
[TBL] [Abstract][Full Text] [Related]
26. Breast conservation among older patients with early-stage breast cancer: Locoregional recurrence following adjuvant radiation or hormonal therapy.
Tringale KR; Berger ER; Sevilimedu V; Wen HY; Gillespie EF; Mueller BA; McCormick B; Xu AJ; Cuaron JJ; Cahlon O; Khan AJ; Powell SN; Morrow M; Heerdt AS; Braunstein LZ
Cancer; 2021 Jun; 127(11):1749-1757. PubMed ID: 33496354
[TBL] [Abstract][Full Text] [Related]
27. Association of Circulating Tumor Cell Status With Benefit of Radiotherapy and Survival in Early-Stage Breast Cancer.
Goodman CR; Seagle BL; Friedl TWP; Rack B; Lato K; Fink V; Cristofanilli M; Donnelly ED; Janni W; Shahabi S; Strauss JB
JAMA Oncol; 2018 Aug; 4(8):e180163. PubMed ID: 29800954
[TBL] [Abstract][Full Text] [Related]
28. Local Relapse After Breast-Conserving Therapy Versus Mastectomy for Extensive Pure Ductal Carcinoma In Situ ≥4 cm.
Hamilton SN; Nichol A; Wai E; Gondara L; Velásquez García HA; Speers C; Diocee R; Truong P
Int J Radiat Oncol Biol Phys; 2019 Feb; 103(2):381-388. PubMed ID: 30253237
[TBL] [Abstract][Full Text] [Related]
29. Is oncotype DX recurrence score (RS) of prognostic value once HER2-positive and. low-ER expression patients are removed?
Milburn M; Rosman M; Mylander C; Tafra L
Breast J; 2013; 19(4):357-64. PubMed ID: 23701403
[TBL] [Abstract][Full Text] [Related]
30. Influence of the time between surgery and radiotherapy on local recurrence in patients with lymph node-positive, early-stage, invasive breast carcinoma undergoing breast-conserving surgery: results of the French Adjuvant Study Group.
Benchalal M; Le Prisé E; de Lafontan B; Berton-Rigaud D; Belkacemi Y; Romestaing P; Peignaux K; Courdi A; Monnier A; Montcuquet P; Goudier MJ; Marchal C; Chollet P; Abadie-Lacourtoisie S; Datchary J; Veyret C; Kerbrat P
Cancer; 2005 Jul; 104(2):240-50. PubMed ID: 15948160
[TBL] [Abstract][Full Text] [Related]
31. Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy.
Arvold ND; Taghian AG; Niemierko A; Abi Raad RF; Sreedhara M; Nguyen PL; Bellon JR; Wong JS; Smith BL; Harris JR
J Clin Oncol; 2011 Oct; 29(29):3885-91. PubMed ID: 21900114
[TBL] [Abstract][Full Text] [Related]
32. Validation of the 21-gene test as a predictor of clinical response to neoadjuvant hormonal therapy for ER+, HER2-negative breast cancer: the TransNEOS study.
Iwata H; Masuda N; Yamamoto Y; Fujisawa T; Toyama T; Kashiwaba M; Ohtani S; Taira N; Sakai T; Hasegawa Y; Nakamura R; Akabane H; Shibahara Y; Sasano H; Yamaguchi T; Sakamaki K; Bailey H; Cherbavaz DB; Jakubowski DM; Sugiyama N; Chao C; Ohashi Y
Breast Cancer Res Treat; 2019 Jan; 173(1):123-133. PubMed ID: 30242578
[TBL] [Abstract][Full Text] [Related]
33. Identification of patients at very low risk of local recurrence after breast-conserving surgery.
Smith SL; Truong PT; Lu L; Lesperance M; Olivotto IA
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):556-62. PubMed ID: 24929165
[TBL] [Abstract][Full Text] [Related]
34. Omitting radiation therapy after lumpectomy for pure DCIS does not reduce the risk of salvage mastectomy.
Rakovitch E; Nofech-Mozes S; Hanna W; Sutradhar R; Gu S; Fong C; Tuck A; Youngson B; Miller N; Done SJ; Chang MC; Sengupta S; Elavathil L; Jani PA; Bonin M; Lalani N; Paszat L
Breast; 2018 Feb; 37():181-186. PubMed ID: 28781102
[TBL] [Abstract][Full Text] [Related]
35. Patterns of adjuvant care and outcomes of elderly women with stage I breast cancer after breast-conserving surgery: a population-based analysis.
Goldberg M; Sutradhar R; Paszat L; Whelan TJ; Gu S; Fong C; Rakovitch E
Breast Cancer Res Treat; 2019 Aug; 176(3):657-667. PubMed ID: 31076954
[TBL] [Abstract][Full Text] [Related]
36. Adjuvant chemotherapy is associated with an overall survival benefit regardless of age in ER+/HER2- breast cancer pts with 1-3 positive nodes and oncotype DX recurrence score 20 to 25: an NCDB analysis.
Stabellini N; Cao L; Towe CW; Luo X; Amin AL; Montero AJ
Front Oncol; 2023; 13():1115208. PubMed ID: 37168373
[TBL] [Abstract][Full Text] [Related]
37. Comparison of breast-conserving surgery without radiotherapy and mastectomy in the treatment of elderly patients with early breast cancer: A PSM and SEER database study.
Fu B; Chen X; Liang W; Wang Y; Yao Y; Zhang J
Cancer Med; 2023 Jul; 12(14):15229-15245. PubMed ID: 37269188
[TBL] [Abstract][Full Text] [Related]
38. Can Radiotherapy After Breast-Conserving Surgery be Omitted in Elderly Patients with Early-Stage, Hormone-Receptor Negative Breast Cancer? A Population-Based Study and Proposed Nomogram.
Xu L; Zhou C; Qiu J; Lv Q; Du Z
Adv Ther; 2022 Oct; 39(10):4707-4722. PubMed ID: 35953665
[TBL] [Abstract][Full Text] [Related]
39. Estimating the overall survival benefit of adjuvant chemo-endocrine therapy in women over age 50 with pT1-2N0 early stage breast cancer and 21-gene recurrence score ≥26: A National Cancer Database analysis.
Stabellini N; Cao L; Towe CW; Amin AL; Montero AJ
Cancer Med; 2023 Oct; 12(19):19607-19616. PubMed ID: 37766666
[TBL] [Abstract][Full Text] [Related]
40. [Prognosis and risk factors of 1 791 patients with breast cancer treated with breast-conserving surgery based on real-world data].
Chen SY; Tang Y; Song YW; Wang SL; Jin J; Liu YP; Wang WH; Fang H; Ren H; Sun GY; Wang JY; Jing H; Zhang JH; Liu XF; Yu ZH; Li YX
Zhonghua Zhong Liu Za Zhi; 2018 Aug; 40(8):619-625. PubMed ID: 30139034
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
